Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-099879
Filing Date
2025-07-30
Accepted
2025-07-30 07:05:53
Documents
74
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrn-20250630.htm   iXBRL 10-Q 2553656
2 EX-10.2 amrn-ex10_2.htm EX-10.2 33004
3 EX-10.3 amrn-ex10_3.htm EX-10.3 80205
4 EX-31.1 amrn-ex31_1.htm EX-31.1 13009
5 EX-31.2 amrn-ex31_2.htm EX-31.2 13685
6 EX-32.1 amrn-ex32_1.htm EX-32.1 14136
7 GRAPHIC img154159145_0.jpg GRAPHIC 284999
  Complete submission text file 0000950170-25-099879.txt   12781160

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT amrn-20250630.xsd EX-101.SCH 1461272
77 EXTRACTED XBRL INSTANCE DOCUMENT amrn-20250630_htm.xml XML 2783140
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 Ireland
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 Ireland 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21392 | Film No.: 251163933
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)